Genetics and Cardiovascular Disease A Policy Statement From the American Heart Association

被引:55
作者
Ashley, Euan A.
Hershberger, Ray E.
Caleshu, Colleen
Ellinor, Patrick T.
Garcia, Joe G. N.
Herrington, David M.
Ho, Carolyn Y.
Johnson, Julie A.
Kittner, Steven J.
MacRae, Calum A.
Mudd-Martin, Gia
Rader, Daniel J.
Roden, Dan M.
Scholes, Derek
Sellke, Frank W.
Towbin, Jeffrey A.
Van Eyk, Jennifer
Worrall, Bradford B.
机构
关键词
AHA Scientific Statements; genetics; ELECTRONIC MEDICAL-RECORDS; PERSONALIZED MEDICINE; DNA BIOBANK; WARFARIN; VKORC1; INFORMATION; RESISTANCE; THERAPY; SOCIETY; HEALTH;
D O I
10.1161/CIR.0b013e31825b07f8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:142 / 157
页数:16
相关论文
共 65 条
[1]   Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[2]  
American Heart Association, 2010, RESP FDA CALL COMM L
[3]   Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome [J].
Angrist, Misha ;
Chandrasekharan, Subhashini ;
Heaney, Christopher ;
Cook-Deegan, Robert .
GENETICS IN MEDICINE, 2010, 12 (04) :S111-S154
[4]  
[Anonymous], 2010, Technol Eval Cent Assess Program Exec Summ, V24, P1
[5]  
[Anonymous], 2011, GEN ED TRAIN
[6]  
[Anonymous], 2010, DIR TO CONS GEN TEST
[7]  
[Anonymous], 2011, B AETN, V0140
[8]  
[Anonymous], 2006, AT HOM GEN TESTS HLT
[9]  
[Anonymous], 2003, FED REGISTER, V68, P55634
[10]  
[Anonymous], JAMA